Finley John David's Form 4 filing
Palisade Bio, Inc. (PALI) · filed Feb 1, 2024
- Accession no.
- 0001493152-24-004566
- Filed
- Feb 1, 2024
- Trade date
- Jan 31, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $5.60K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Finley John DavidCIK 0001851034 | Director, Officer (CEO, CFO, Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2024 | Common Stock, par value $0.01 | PPurchaseAcquired | +10,000 | $0.56F1 | +$5,600 | 74,649 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Reporting Person purchased 10,000 shares of Common Stock at a price per share of $0.559.
Referenced by the price of 1 transaction in Table I.